(Q33706238)

28 July 2017

1 reference

title

Platelet microparticles: a wide-angle perspective (English)

1 reference

28 July 2017

Horstman LL

1

1 reference

PubMed ID

10439058

28 July 2017

Ahn YS

series ordinal

2

1 reference

28 July 2017

1 April 1999

1 reference

Critical Reviews in Oncology Hematology

28 July 2017

1 reference

28 July 2017

30

1 reference

28 July 2017

111-142

1 reference

28 July 2017

2

1 reference

The platelet-like activity of serum

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The Nature and Significance of Platelet Products in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet aggregation and the availability of platelet factor 3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The role of platelet microparticles in hemostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Microthrombocytosis and Platelet Fragmentation Associated with Idiopathic/Autoimmune Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet storage lesion: formation of platelet fragments with platelet factor 3 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Characterization of snake venom components acting on blood coagulation and platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Action of snake venom components on the haemostatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

STUDIES ON PLATELET FACTOR-3 AVAILABILITY

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A highly sensitive assay of platelet factor 3 using a chromogenic substrate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Coagulation activities of plasma microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Soybean Phosphatides in Prothrombin-Consumption and Thromboplastin-Generation Tests: Their Use in Recognizing “Thrombasthenic Hemophilia”

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Analysis of platelet factor 3 in platelet concentrates stored for transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A new method for the determination of prothrombin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Blood platelet heterogeneity: evidence for two classes of platelets in man and rat

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Surface recruitment but not activation of integrin alpha IIb beta 3 (GPIIb-IIIa) requires a functional actin cytoskeleton.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet alpha-granules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet microparticles: a carrier of platelet-activating factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Amyloid beta-protein precursor: a new anticoagulant?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Procoagulant activity and active calpain in platelet-derived microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The presence of contractile proteins in platelet microparticles isolated from human and animal platelet-free plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Association of localized Ca2+ gradients with redistribution of glycoprotein IIb-IIIa and F-actin in activated human blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A contribution to the theory of permeability of thin films

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Transbilayer movement of phospholipids in red cell and platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Prothrombin activation on phospholipid membranes with positive electrostatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Original Article: Electrophoretic Properties of Platelets from Normal, Thrombotic and ITP Patients by Doppler Electrophoretic Light Scattering Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antiphospholipid antibody-dependent C5b-9 formation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Masking of heparin activity in the activated coagulation time (ACT) by platelet procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Release of diacylglycerol-enriched vesicles from erythrocytes with increased intracellular [Ca2+]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The effect of spicules obtained from sickle red cells on clotting activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effect of red blood cells from patients with sickle cell disease on platelet factor 3 release

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effect of membrane cholesterol on dimyristoylphosphatidylcholine-induced vesiculation of human red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effect of dimyristoyl phosphatidylcholine on intact erythrocytes. Release of spectrin-free vesicles without ATP depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet microparticles bind, activate and aggregate neutrophils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Chylomicron-induced prothrombin activation and platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Differential susceptibility of immune complexes to release from the erythrocyte CR1 receptor by factor I

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Receptors that Activate Platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

1 reference

7 January 2021

Disorders of platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The appearance of multivesicular structures during platelet activation as observed by scanning electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Expression of coagulant activity in human platelets: Release of membranous vesicles providing platelet factor 1 and platelet factor 3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Involvement of Phospholipase A2in H2O2-dependent Platelet Activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Human platelet activation by C3a and C3a des-arg

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Neutrophil priming: the cellular signals that say 'amber' but not 'green'.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet-activating factor (PAF): implications for coronary heart and vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet-activating factor in stroke and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Biochemical pharmacology of platelet-activating factor (and paf antagonists) in relation to clinical and experimental thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Therapy of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasmin inhibition of platelet function and of arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasmin accelerates platelet-dependent prothrombinase formation without activating the platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Duality of plasmin effect on cytosolic free calcium in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Membrane proteins that protect against complement lysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Secretion of the terminal complement proteins, C5-C9, by human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Big MAC attack: complement proteins cause leaky patches

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The response of human platelets to activated components of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-platelet antibody interactions with Fc gamma receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Extensive C1q-complement initiated lysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The structural requirements for complement activation by IgG: does it hinge on the hinge?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Functional effects of human antiplatelet antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

New monoclonal anti-human Fc gamma receptor II antibodies induce platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet antibodies of the IgM class in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

In vitro fixation of C3d and C5b-9 on platelets by human platelet reactive antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet associated complement components (PAC3c and PAC3d) in patients with autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet-associated complement in chronic ITP.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Complement-mediated permeabilization of platelets by monoclonal antibodies to CD9: inhibition by leupeptin, and effects on the GP Ib-actin-binding protein system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Red-Cell and Platelet Fragmentation in Idiopathic Autoimmune Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The Fc receptor for immunoglobulin G (Fc gamma RII) on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Induction of patching and its reversal on surface-activated human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Functional significance of mobile receptors on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Molecular specificity of anti-IIb/IIIa human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Fc receptors and immunoglobulin binding factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Activated platelet aggregates in thrombotic thromboctyopenic purpura: decrease with plasma infusions and normalization in remission

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet aggregates as markers of platelet activation: characterization of flow cytometric method suitable for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-GPIIb/IIIa antibodies: powerful tools to investigate function and regulation of an integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Immune thrombocytopenic purpura: autoimmune or immune complex disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Detection of platelet antigen for antiplatelet antibodies in idiopathic thrombocytopenic purpura by flow cytometry, antigen-capture ELISA, and immunoblotting: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Clinical role of antiplatelet antibody assays

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Mechanisms of assembly and disassembly of microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Temperature-dependent reversible assembly of taxol-treated microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Formation of a cryogel during processing of cell-free plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The effect of shear rate on platelet interaction with subendothelium exposed to citrated human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Hemodialysis-associated platelet activation and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Biocompatibility of dialysis membranes: Effects of chronic complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

More to "heparin" than anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Heparins designed to specifically inhibit platelet interactions with von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Congenital thrombocytopathy (platelet factor 3 defect) with prolonged bleeding time but normal platelet adhesiveness and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Letter: Isolated platelet factor 3 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Isolated deficiency of platelet procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The skin bleeding time test as a predictor of brain bleeding time in a rat model.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Enhanced in vivo platelet activation in subtypes of ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Cerebrovascular injuries induced by activation of platelets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasminogen activator inhibitor is elevated in plasma and diminished in platelets in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet microparticles and calcium homeostasis in acute coronary ischemias

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Thrombosis in patients with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Factor H co-purifies with thrombospondin isolated from platelet secretate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antiphospholipid antibodies and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antiphospholipid antibodies: basic immunology and assays

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

A new lupus anticoagulant neutralization test based on platelet-derived vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-glycoprotein IIb/IIIa autoantibodies are reversibly internalized into platelets in idiopathic (autoimmune) thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Autoimmunity. The pathogen connection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Elevated platelet-associated IgG in SLE patients due to anti-platelet autoantibody: differentiation between autoantibodies and immune complexes by ether elution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Anti-annexin V antibodies in plasma and serum samples from patients with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Annexin V autoantibodies in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Inhibitory effect of platelet factor 4 on human erythroleukemic cells is dependent on cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Immune endothelial-cell injury in heparin-associated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet stickiness in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet behaviour and plasma phospholipids in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet behaviour in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Plasma and platelet phospholipids in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet activation in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

The Ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba L.. Chemistry, pharmacology and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Early neurological complications of coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Neurological complications of open heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Central nervous system complications in coronary artery bypass graft surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Neurologic complications of coronary artery bypass grafting: diffuse or focal ischemia?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet secretory products may contribute to neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled tr

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Altered influence of polymorphonuclear leukocytes on coagulation in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Tissue factor expression on macrophages in coronary plaques in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Human neutrophil cathepsin G is a potent platelet activator

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Microparticle release from platelets by leukemic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Platelet microvesicles adhere to subendothelium and promote adhesion of platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Activated human platelets express beta2 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Rho GTPases and the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2898%2900044-4

7 January 2021

10.1016/S1040-8428(98)00044-4

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10439058